Pharmaceutical Technology's In the Lab eNewsletter
Protagen Protein Services’ recently acquired Brucker Tensor II IR spectrometer significantly expands the company’s analytical capabilities.
Protagen Protein Services’ (PPS) recently acquired Brucker Tensor II IR spectrometer, which uses Fourier-Transform infrared (FT–IR) spectroscopy technology, significantly enhances the company’s analytical capabilities. The company acquired the new spectrometer in August 2019. Equipped with an AquaSpec transmission cell, the advanced instrument completes and refines the company’s characterization service package by enabling higher order structural characterization as well as providing elaborate results in a relatively short time period.
FT–IR spectroscopy is highly sensitive to the secondary structure of proteins and has been widely used to investigate protein folding. A protein’s secondary structure features-such as alpha helices, beta sheets, and other conformations-are critical parameters that must be assessed diligently.
Comprehensive information on the numerous structural attributes of a protein therapeutic is vital for understanding a protein’s functionality, stability, and antigenicity. FT–IR spectrometers are powerful tools for characterizing the advanced structure of protein-based biologics. They also allow for the monitoring of vibrational modes of the amide bonds within a protein while in its native state and formulation matrix.
While a protein will display many infrared-absorbing bands, amide band I is quite sensitive and representative of the protein conformational states. It is thus used to discern the relative amounts of different types of secondary structure. Together with circular dichroism, FT–IR is part of a comprehensive platform in the characterization of a biologic's secondary structure profile.
The Brucker Tensor II IR spectrometer can conduct rapid and sensitive assays with a high degree of throughput and allows for accelerated data acquisition while at the same time requiring low sample amounts. The transmission cell is specially designed to analyze proteins in aqueous solution. The spectrometer’s FT–IR capability can also be used to analyze buffer components (salts, detergents, excipients). While other stability indicating methods such as differential scanning calorimetry, dynamic light scattering, or hydrogen deuterium exchange–mass spectrometry remain substantial for any protein research object’s analysis, this new platform expands PPS’ range of services and completes overall biopharmaceutical characterization, stability and comparability studies, biosimilarity assessment, and formulation development.
Source: Protagen Protein Services
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
In Wake of Trump Tariffs, Lilly Plans New US Pharmaceutical Manufacturing Sites
February 26th 2025Previous domestic capital expansion commitments since 2020 had been made in Research Triangle Park and Concord, both in North Carolina; Kenosha County, Wisconsin; Lebanon, Indiana; and Lilly’s home city of Indianapolis.
Cosette Pharmaceuticals Adds to Dermatology and Women’s Health Portfolio with Mayne Pharma Purchase
Published: February 26th 2025 | Updated: February 26th 2025While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of the acquisition.